DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,835,068 | +3.6% | 15,458 | +0.2% | 0.53% | +6.5% |
| Q2 2023 | $3,700,740 | -0.3% | 15,420 | +4.7% | 0.49% | -7.8% |
| Q1 2023 | $3,710,635 | -6.6% | 14,722 | -1.7% | 0.54% | -14.1% |
| Q4 2022 | $3,973,452 | -4.3% | 14,970 | -6.9% | 0.62% | -12.4% |
| Q3 2022 | $4,152,000 | -10.5% | 16,074 | +0.9% | 0.71% | -1.5% |
| Q2 2022 | $4,639,000 | +2.7% | 15,933 | +3.5% | 0.72% | +6.8% |
| Q1 2022 | $4,517,000 | -6.6% | 15,401 | +4.8% | 0.68% | +24.7% |
| Q4 2021 | $4,837,000 | +11.6% | 14,701 | +3.2% | 0.54% | -3.2% |
| Q3 2021 | $4,335,000 | +7.1% | 14,239 | -5.6% | 0.56% | +24.4% |
| Q2 2021 | $4,049,000 | +31.4% | 15,087 | +10.2% | 0.45% | +50.3% |
| Q1 2021 | $3,082,000 | +8.7% | 13,692 | +7.2% | 0.30% | +18.6% |
| Q4 2020 | $2,836,000 | +15.3% | 12,769 | +11.8% | 0.25% | +13.5% |
| Q3 2020 | $2,459,000 | +46.1% | 11,422 | +20.0% | 0.22% | +28.2% |
| Q2 2020 | $1,683,000 | +4.6% | 9,518 | -18.1% | 0.17% | -16.3% |
| Q1 2020 | $1,609,000 | -1.5% | 11,628 | +9.2% | 0.21% | +16.9% |
| Q4 2019 | $1,634,000 | +26.1% | 10,648 | +18.7% | 0.18% | +12.7% |
| Q3 2019 | $1,296,000 | +5.5% | 8,974 | +4.5% | 0.16% | +12.9% |
| Q2 2019 | $1,228,000 | +21.5% | 8,589 | +12.2% | 0.14% | +19.7% |
| Q1 2019 | $1,011,000 | +34.3% | 7,654 | +4.9% | 0.12% | +14.7% |
| Q4 2018 | $753,000 | +97.1% | 7,298 | +107.9% | 0.10% | +117.0% |
| Q3 2018 | $382,000 | +26.1% | 3,511 | +14.3% | 0.05% | +17.5% |
| Q2 2018 | $303,000 | +7.1% | 3,073 | +6.2% | 0.04% | +2.6% |
| Q1 2018 | $283,000 | +24.7% | 2,894 | +18.4% | 0.04% | +25.8% |
| Q4 2017 | $227,000 | – | 2,444 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |